Assistance Fund: Sickle Cell Disease (SCD): Waitlist

Funded
About
The Assistance Fund: Sickle Cell Disease (SCD): Waitlist program provides essential financial support to patients prescribed with FDA-approved treatments such as Ferriprox, Adakveo, Endari, Siklos, and others. This program offers copay and financial assistance to eligible U.S. citizens or permanent residents diagnosed with Sickle Cell Disease, ensuring they can afford necessary treatments and related medical expenses. With opportunities for conditional approval and coverage of off-label drugs, the Assistance Fund: Sickle Cell Disease (SCD): Waitlist ensures patients receive the care needed without financial burden.
Insurance requirements: Commercially insured, Medicare / Medicaid
Enrollment Forms
Enrollment Form
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: Yes
•Activation Required: No
Program Details
•Please note the following:
•1. Copay grant programs provide assistance for copays, coinsurance, and deductibles for FDAapproved treatment for the disease named in the disease program ONLY
•2. Financial assistance grant programs provide assistance for other eligible outofpocket costs, such as health insurance premiums and incidental medical expenses, in addition to copay, coinsurance, and deductible assistance on FDAapproved treatment for the disease named in the disease program
•3. This fund may cover offlabel drugs
•Copay and Financial assistance can be utilized by any innetwork pharmacy or site of care able to dispense the medication or provide treatment
•Program offers conditional approval of 30 days of immediate assistance for open programs where funding is available
•Patients will be asked to provide and verify demographic, insurance, and financial information (additional documentation may be requested)
•Approved patients will be granted assistance through the end of the calendar year unless otherwise specified for the applicable program
Other Programs

HealthWell: Sickle Cell Disease

Commercially Insured
Medicare / Medicaid
Max Saving: $10000/year*

PAF Co-Pay Relief: Sickle Cell Disease

Commercially Insured
Medicare / Medicaid
Max Saving: $3500/year*